PolyPid is a developer of a polymer lipid-based technology created to extend the release of drugs to prevent infection.
PolyPid’s technology is a clinical state, emerging pharmaceutical process that is developing, manufacturing and eventually commercializing products based on its proprietary polymer-lipid encapsulation matrix platform and is focused on infection treatment and prevention, beginning with treatment of surgical site infections, enabling clients to improve patient outcomes and offer efficient treatment.
INDUSTRY
MILESTONES
Founded: 2008
Arc investment: 2016
LATEST NEWS
/PRNewswire/ — PolyPid Ltd., a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release…